The legacy status of Viagra, and the parent corporation copyright, presents a complex question for investors . While profits initially soared , the impending patent lapse and growing generic presence https://pennygfxd398542.blogs100.com/41909821/the-blue-pill-and-the-pharmaceutical-industry-a-speculative-investment